Detalles de la búsqueda
1.
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.
Cardiovasc Diabetol
; 22(1): 233, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37653496
2.
Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis.
Diabetes Res Clin Pract
; 174: 108734, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33737213
3.
The DIVE/DPV registries: evolution of empagliflozin use in clinical practice in Germany.
BMJ Open Diabetes Res Care
; 8(1)2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32719080
4.
Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage.
Diabetes Metab Syndr Obes
; 12: 1225-1237, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31440070
5.
Titration of basal insulin or immediate addition of rapid acting insulin in patients not at target using basal insulin supported oral antidiabetic treatment - A prospective observational study in 2202 patients.
Diabetes Metab Syndr
; 11(1): 51-57, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27578616
6.
No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes.
Diabetes Care
; 33(7): 1443-8, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20357369
Resultados
1 -
6
de 6
1
Próxima >
>>